XML 40 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Other Paid-in Capital
Retained Earnings
Deferred Retirement Benefit Costs
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Total Ameren Corporation Shareholders' Equity
Union Electric Company
Union Electric Company
Common Stock
Union Electric Company
Other Paid-in Capital
Union Electric Company
Preferred Stock
Union Electric Company
Retained Earnings
Ameren Illinois Company
Ameren Illinois Company
Common Stock
Ameren Illinois Company
Other Paid-in Capital
Ameren Illinois Company
Preferred Stock
Ameren Illinois Company
Retained Earnings
Beginning of year at Dec. 31, 2019     $ 5,694 $ 2,380 $ (17)   $ 142       $ 2,027   $ 1,731     $ 2,188 $ 62 $ 1,882
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Settlement of forward sale agreement through common shares issuance     0                              
Shares issued under the DRPlus and 401(k) plan     13                              
Stock-based compensation activity     (12)                              
Capital contribution from parent                 $ 0   0     $ (100)   100    
Net income $ 148               (9)       (9) 121       121
Net income attributable to Ameren common shareholders 146     146                            
Dividends on common stock       (122)                            
Preferred stock dividends                         (1)         (1)
Change in deferred retirement benefit costs 1       1                          
Net income attributable to noncontrolling interest holders $ (2)           2                      
Dividends paid to noncontrolling interest holders             (2)                      
Redemptions of preferred stock     0                         0    
Common stock shares outstanding at beginning of year (in shares) at Dec. 31, 2019 246,200,000                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan (in shares) 200,000                                  
Shares issued for stock-based compensation (in shares) 500,000                                  
Common stock shares outstanding at end of period (in shares) at Mar. 31, 2020 246,900,000                                  
End of period at Mar. 31, 2020 $ 8,227 $ 2 5,695 2,404 (16) $ (16) 142     $ 511 2,027 $ 80 1,721   $ 0 2,288 62 2,002
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share (in dollars per share) $ 0.495                                  
Shareholders' equity, end of year at Mar. 31, 2020               $ 8,085 4,339         4,352        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under forward sale agreement (in shares) 0                                  
Beginning of year at Dec. 31, 2020 $ 9,080   6,179 2,757 (1)   142       2,518   2,101     2,652 62 2,252
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Settlement of forward sale agreement through common shares issuance     113                              
Shares issued under the DRPlus and 401(k) plan     12                              
Stock-based compensation activity     (9)                              
Capital contribution from parent                 (113)   113     (40)   40    
Net income 235               $ 48       48 $ 150       150
Net income attributable to Ameren common shareholders 233     233                            
Dividends on common stock       (140)                            
Preferred stock dividends                         (1)         (1)
Change in deferred retirement benefit costs 1       1                          
Net income attributable to noncontrolling interest holders $ (2)           2                      
Dividends paid to noncontrolling interest holders             (2)                      
Redemptions of preferred stock     13                         13    
Common stock shares outstanding at beginning of year (in shares) at Dec. 31, 2020 253,300,000               102,100,000         25,500,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan (in shares) 100,000                                  
Shares issued for stock-based compensation (in shares) 500,000                                  
Common stock shares outstanding at end of period (in shares) at Mar. 31, 2021 255,500,000               102,100,000         25,500,000        
End of period at Mar. 31, 2021 $ 9,277 $ 3 $ 6,295 $ 2,850 $ 0 $ 0 $ 129     $ 511 $ 2,631 $ 80 $ 2,148   $ 0 $ 2,692 $ 49 $ 2,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share (in dollars per share) $ 0.550                                  
Shareholders' equity, end of year at Mar. 31, 2021 $ 9,148             $ 9,148 $ 5,370         $ 5,142        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under forward sale agreement (in shares) 1,600,000